Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.

Saved in:
Bibliographic Details
Title: Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Authors: Burger PM; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, NY 10029, USA., Dorresteijn JAN; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands., Koudstaal S; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Green Heart Hospital, Gouda 2803 HH, the Netherlands., Mosterd A; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Meander Medical Centre, Amersfoort 3813 TZ, the Netherlands., Martens FMAC; Dutch Cardiovascular Research Network (WCN), Utrecht 3511 EP, the Netherlands.; Department of Cardiology, Amsterdam University Medical Centre, Amsterdam 1105 AZ, the Netherlands., Steg PG; Université Paris-Cité, LVTS, French Alliance for Cardiovascular Trials (FACT), Assistance Publique-Hôpitaux de Paris, Paris 75018, France., Visseren FLJ; Department of Vascular Medicine, University Medical Centre Utrecht, Utrecht 3584 CX, the Netherlands.
Corporate Authors: REDUCE-IT Investigators
Source: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Oct 04; Vol. 10 (6), pp. 488-499.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2055-6845
DOI:10.1093/ehjcvp/pvae030